Takayasu Fukudome

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

Acetylcholine receptors loss and postsynaptic damage in MuSK antibody–positive myasthenia gravis

Hirokazu Shiraishi, Masakatsu Motomura, Toshiro Yoshimura et al. · Annals of Neurology · 2005 · 171 citations

Slow-channel myasthenic syndrome caused by enhanced activation, desensitization, and agonist binding affinity attributable to mutation in the M2 domain of the acetylcholine receptor alpha subunit.

Margherita Milone, Hai Long Wang, Kinji Ohno et al. · PubMed · 1997 · 134 citations

Agonist Binding Affinity, Molecular Biology, Mechanotransduction +20

Slow-Channel Myasthenic Syndrome Caused By Enhanced Activation, Desensitization, and Agonist Binding Affinity Attributable to Mutation in the M2 Domain of the Acetylcholine Receptor α Subunit

Margherita Milone, Hailong Wang, Kinji Ohno et al. · Journal of Neuroscience · 1997 · 125 citations · Full text

Synaptic Transmission, Molecular Biology, Synaptic Signaling +22

Myopathy, Myasthenic Syndrome, and Epidermolysis Bullosa Simplex Due to Plectin Deficiency

Brenda Banwell, James T. Russel, Takayasu Fukudome et al. · Journal of Neuropathology & Experimental Neurology · 1999 · 112 citations · Full text

Plectin Expression, Skeletal Muscle, Medicine +15